EI

Exide Inds.

Q4 FY26Auto Components

Exide Inds. Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price460
Market cap₹39.1K Cr
P/E41.6
Updated23 Aug 2026
Read5 min read

The short version

Medium-term CAGR for the core lead-acid battery business is expected to be mid-to-high single digits to early double digits, similar to the past five years' CAGR of around 11% (+/-1%). Core lead-acid battery business is expected to grow at mid-to-high single-digit to early double-digit CAGR over the next 3-5 years, consistent with past five-year growth (~11% CAGR). - Auto OEM business has recorded 20-25% growth in recent quarters, expected to drive aftermarket growth after 2 years. - EBITDA margin improved by about 50 basis points year-on-year in FY26, showing margin resilience despite commodity cost pressures. - Lithium-ion business is ramping up with Rs.

From Exide Inds.'s Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Medium-term CAGR for the core lead-acid battery business is expected to be mid-to-high single digits to early double digits, similar to the past five years' CAGR of around 11% (+/-1%).
  • Automotive OEM business is growing 20-25% and is expected to drive aftermarket growth in 2 years.
  • Domestic business sales grew 12.5% YoY in Q4; full-year FY26 domestic growth was about 7.5%.
  • Two-wheeler and four-wheeler replacement markets, home UPS, solar, and industrial infrastructure businesses show robust double-digit growth.
  • Export revenues expected to recover and grow from a low base as geopolitical tensions ease (Exports ~5% of top line).

2 more points management made on revenue & sales performance

Profitability & Margins

See what Exide Inds. said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Exide Industries has invested approximately Rs. 4,800 crores in its lithium-ion cell manufacturing subsidiary, Exide Energy, to date.
  • An additional capital expenditure of Rs. 1,400 crores is approved and planned for FY27, covering both CAPEX and OPEX requirements for Phase-I.
  • The total expected investment in the lithium-ion business, including past and planned amounts, is around Rs. 6,200-6,500 crores.
  • Investments focus on establishing a 6-gigawatt capacity split evenly between cylindrical (NMC chemistry) and prismatic (LFP chemistry) cells.

2 more points management made on capital expenditure plans

Top-ranked in Auto Components

Ranked on what management guided this quarter

5x potential
1Divgi Torq
Rev 1Mar 3
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Exide Inds. said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided transcript does not explicitly mention the current or expected order book or pending orders for Exide Industries Limited. However, the following related points can be inferred: - The company is ramping up lithium-ion cell manufacturing capacity, with 6 gigawatts capacity planned in Phase-I (3 GWh cylindrical, 3 GWh prismatic). - Additional capacity through a separate contract with Hyundai is incremental and not included in the current 6 gigawatt capacity. - Customer validation for cylindrical cells is about 2-3 months; prismatic cells are expected to have quicker market entry.

2 more points management made on order book & pipeline

Exide Inds. — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹4.7K Cr, net profit ₹217 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Auto Components this season

  • Precision Camshf (Q4 FY26)

    Precision Camshafts Limited has a healthy order book of INR1,500 crores to be executed over the next 5-6 years, supporting long-term growth. Key concall…

  • Kranti Industrie (Q4 FY26)

    FY26 marked crossing ₹100 crore consolidated revenue milestone, with optimism for continued ramp-up. Key concall takeaways from Kranti Industrie's Q4 FY26…

  • CEAT Ltd (Q4 FY26)

    Price increases planned: around 5% taken between March-April; additional 5% staggered through May-June, totaling a 10% replacement price hike. Key concall…

  • Balkrishna Inds (Q4 FY26)

    OHT business volumes increased by 5% in the latest quarter; growth momentum seen in H2 FY '26 over H1. Key concall takeaways from Balkrishna Inds's Q4 FY26…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Exide Inds. Q4 FY26 results?

Medium-term CAGR for the core lead-acid battery business is expected to be mid-to-high single digits to early double digits, similar to the past five years' CAGR of around 11% (+/-1%). Core lead-acid battery business is expected to grow at mid-to-high single-digit to early double-digit CAGR over the next 3-5 years, consistent with past five-year growth (~11% CAGR). - Auto OEM business has recorded 20-25% growth in recent quarters, expected to drive aftermarket growth after 2 years. - EBITDA margin improved by about 50 basis points year-on-year in FY26, showing margin resilience despite commodity cost pressures. - Lithium-ion business is ramping up with Rs.

What is Exide Inds. share price analysis?

Exide Inds. currently shows a neutral. The stock trades at a P/E of 41.6 with a market cap of ₹39,066 Cr. Investors should review the full earnings analysis for detailed insights.

Is Exide Inds. planning capital expenditure?

Exide Industries has invested approximately Rs.

Keep Exide Inds. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.